158 related articles for article (PubMed ID: 30522694)
1. CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.
Cuenca M; Sintes J; Lányi Á; Engel P
Clin Immunol; 2019 Jul; 204():43-49. PubMed ID: 30522694
[TBL] [Abstract][Full Text] [Related]
2. CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.
Lewinsky H; Barak AF; Huber V; Kramer MP; Radomir L; Sever L; Orr I; Mirkin V; Dezorella N; Shapiro M; Cohen Y; Shvidel L; Seiffert M; Herishanu Y; Becker-Herman S; Shachar I
J Clin Invest; 2018 Dec; 128(12):5465-5478. PubMed ID: 30277471
[TBL] [Abstract][Full Text] [Related]
3. CD84 mediates CLL-microenvironment interactions.
Marom A; Barak AF; Kramer MP; Lewinsky H; Binsky-Ehrenreich I; Cohen S; Tsitsou-Kampeli A; Kalchenko V; Kuznetsov Y; Mirkin V; Dezorella N; Shapiro M; Schwartzberg PL; Cohen Y; Shvidel L; Haran M; Becker-Herman S; Herishanu Y; Shachar I
Oncogene; 2017 Feb; 36(5):628-638. PubMed ID: 27452524
[TBL] [Abstract][Full Text] [Related]
4. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance.
Wong EB; Soni C; Chan AY; Domeier PP; Shwetank ; Abraham T; Limaye N; Khan TN; Elias MJ; Chodisetti SB; Wakeland EK; Rahman ZS
J Immunol; 2015 May; 194(9):4130-43. PubMed ID: 25801429
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
6. CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
Lewinsky H; Gunes EG; David K; Radomir L; Kramer MP; Pellegrino B; Perpinial M; Chen J; He TF; Mansour AG; Teng KY; Bhattacharya S; Caserta E; Troadec E; Lee P; Feng M; Keats J; Krishnan A; Rosenzweig M; Yu J; Caligiuri MA; Cohen Y; Shevetz O; Becker-Herman S; Pichiorri F; Rosen S; Shachar I
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33465053
[TBL] [Abstract][Full Text] [Related]
7. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
8. CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis.
Zheng N; Fleming J; Hu P; Jiao J; Zhang G; Yang R; Li C; Liu Y; Bi L; Zhang H
Microbiol Spectr; 2022 Feb; 10(1):e0155721. PubMed ID: 35196822
[TBL] [Abstract][Full Text] [Related]
9. Structure of CD84 provides insight into SLAM family function.
Yan Q; Malashkevich VN; Fedorov A; Fedorov E; Cao E; Lary JW; Cole JL; Nathenson SG; Almo SC
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10583-8. PubMed ID: 17563375
[TBL] [Abstract][Full Text] [Related]
10. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1.
Martin M; Romero X; de la Fuente MA; Tovar V; Zapater N; Esplugues E; Pizcueta P; Bosch J; Engel P
J Immunol; 2001 Oct; 167(7):3668-76. PubMed ID: 11564780
[TBL] [Abstract][Full Text] [Related]
11. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Mediated Slamf1Δ/Δ Slamf5Δ/Δ Slamf6Δ/Δ Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects.
Hu JK; Crampton JC; Locci M; Crotty S
PLoS One; 2016; 11(5):e0156074. PubMed ID: 27223891
[TBL] [Abstract][Full Text] [Related]
13. Mouse CD84 is a pan-leukocyte cell-surface molecule that modulates LPS-induced cytokine secretion by macrophages.
Sintes J; Romero X; de Salort J; Terhorst C; Engel P
J Leukoc Biol; 2010 Oct; 88(4):687-97. PubMed ID: 20628063
[TBL] [Abstract][Full Text] [Related]
14. CD84 is a survival receptor for CLL cells.
Binsky-Ehrenreich I; Marom A; Sobotta MC; Shvidel L; Berrebi A; Hazan-Halevy I; Kay S; Aloshin A; Sagi I; Goldenberg DM; Leng L; Bucala R; Herishanu Y; Haran M; Shachar I
Oncogene; 2014 Feb; 33(8):1006-16. PubMed ID: 23435417
[TBL] [Abstract][Full Text] [Related]
15. The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases.
Dragovich MA; Mor A
Autoimmun Rev; 2018 Jul; 17(7):674-682. PubMed ID: 29729453
[TBL] [Abstract][Full Text] [Related]
16. The leukocyte receptor CD84 inhibits Fc epsilon RI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells.
Oliver-Vila I; Saborit-Villarroya I; Engel P; Martin M
Mol Immunol; 2008 Apr; 45(8):2138-49. PubMed ID: 18243321
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.
Hofmann S; Braun A; Pozgaj R; Morowski M; Vögtle T; Nieswandt B
PLoS One; 2014; 9(12):e115306. PubMed ID: 25551754
[TBL] [Abstract][Full Text] [Related]
18. CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute Stroke.
Schuhmann MK; Stoll G; Bieber M; Vögtle T; Hofmann S; Klaus V; Kraft P; Seyhan M; Kollikowski AM; Papp L; Heuschmann PU; Pham M; Nieswandt B; Stegner D
Circ Res; 2020 Sep; 127(8):1023-1035. PubMed ID: 32762491
[TBL] [Abstract][Full Text] [Related]
19. Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.
De Salort J; Sintes J; Llinàs L; Matesanz-Isabel J; Engel P
Immunol Lett; 2011 Jan; 134(2):129-36. PubMed ID: 20933013
[TBL] [Abstract][Full Text] [Related]
20. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Farhangnia P; Ghomi SM; Mollazadehghomi S; Nickho H; Akbarpour M; Delbandi AA
Front Immunol; 2023; 14():1174138. PubMed ID: 37251372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
